Skip to content

02Research · Supplement

Vitamin A

Measured against the 58-marker panel. Human studies found an effect on 4, no change in 8 and conflicting results on 11; 35 have no result yet (no trial found for 18, studied only in combination for 13, not yet reviewed for 4).

  • Supported 4
  • No effect 8
  • Conflicting 11
  • No result yet 35
207Studies tracked
14Meta-analyses
186Randomized trials

01Read first

Who should be careful

From the dossier's safety review: 32 cautions and 3 interactions, 18 rated serious. They summarize research and labels; they are not advice for you.

Cautions32

  • SeriousChildren (excessive vitamin A intake)Grade A

    Excessive levels of vitamin A reported to harm the respiratory and skeletal systems in children.

  • SeriousHigher vitamin A intake or elevated serum retinolGrade A

    Outcomes-based systematic reviews and meta-analyses found positive associations between vitamin A intake and serum retinol levels with risk of hip fracture.

  • SeriousInfants of supplemented postpartum womenGrade A

    Infants of supplemented postpartum women showed bulging fontanelle at 24 to 48 hours as an adverse outcome in one RCT with 444 participants, based on low-quality evidence.

  • SeriousLower blood retinol levelGrade A

    Lower blood retinol level was associated with slightly increased hip fracture risk (RR 1.27, 95% CI 1.05–1.53) in a meta-analysis of cohort studies.

Show 28 more
  • SeriousSmokersGrade A

    Retinyl palmitate combined with beta carotene was associated with increased risk of lung cancer among smokers in the CARET trial.

  • SeriousChronic high vitamin A intake for acne vulgarisGrade D

    A 17-year-old developed benign intracranial hypertension with bilateral papilledema and bilateral transverse sinus obstruction following chronic vitamin A intake of 150,000 units daily for acne vulgaris.

  • SeriousElderly with long-term vitamin A supplement useGrade D

    In elderly people, greater fasting plasma retinyl esters were associated with long-term vitamin A supplement use (more than 5 years) and biochemical evidence of liver damage.

  • SeriousHigh liver vitamin A concentrationsGrade D

    High concentrations of vitamin A in the liver were reported as toxic in the context of a study of cystic fibrosis patients, while normal liver concentrations were described as potentially protective against liver damage.

  • SeriousHuman alcoholicsGrade D

    Depleted hepatic vitamin A content was reported in human alcoholics, with altered hepatic retinoid metabolism considered in the context of alcoholic liver disease.

  • SeriousHypervitaminosis AGrade D

    Hypervitaminosis A was reported to have a number of remarkable negative consequences, with some cases described as potentially fatal.

  • SeriousLong-term high intakeGrade D

    Liver biopsy in a patient with chronic high vitamin A intake showed characteristic signs of hypervitaminosis A without fibrosis.

  • SeriousLong-term retinoid useGrade D

    Long-term use of retinoids is associated with risks including teratogenicity, reported in the context of first- and second-generation retinoids applied therapeutically for skin cell function and oncological diseases.

  • SeriousPediatric chronic high vitamin A intakeGrade D

    A nine-year-old female with vitamin A intoxication had demineralized bones and retarded skeletal maturation identified on radiographic studies.

  • SeriousPreadolescent children with cystic fibrosis and pancreatic insufficiencyGrade D

    High vitamin A intakes and elevated serum retinol in children with CF and PI were associated with possible toxicity reported to increase the risk of CF-associated liver and bone complications.

  • SeriousPregnancyGrade D

    Oral vitamin A was reported to carry teratogenicity, identified as a property of the compound alongside its potential for toxicity and long half-life.

  • SeriousRetinol supplementationGrade D

    Retinol has intrinsic hepatotoxicity, which complicates its use in correcting vitamin A deficiency through supplementation, particularly in people who also consume alcohol.

  • SeriousVLBW infants receiving therapeutic vitamin A amountsGrade D

    Vitamin A hepatotoxicity was described in a cohort of 41 VLBW patients receiving therapeutic amounts of vitamin A.

  • ModerateAdequately nourished childrenGrade A

    High-intake Vitamin A supplementation was associated with adverse outcomes related to respiratory infection, diarrhea, and growth in children who were predominantly adequately nourished.

  • ModerateChildren in developed regions with higher baseline serum retinolGrade A

    Children in developed regions have higher baseline serum retinol levels, which may predispose them to immunosuppressive effects associated with high-amount vitamin A supplementation.

  • ModerateChronic high intake (oil-based preparations)Grade A

    A meta-analysis of case reports found that chronic hypervitaminosis A was induced after daily intakes of 2 mg retinol/kg in oil-based preparations sustained for many months or years.

  • ModerateChronic intake (water-miscible, emulsified, and solid preparations)Grade A

    Chronic hypervitaminosis A was induced at intakes as low as 0.2 mg retinol/kg/day in water-miscible, emulsified, and solid preparations sustained for only a few weeks.

  • ModerateNeonatesGrade A

    Minimal acute adverse effects were reported in apparently healthy neonates following high-intake oral vitamin A supplementation.

  • ModerateResected stage I lung cancer patientsGrade B

    Among treated patients receiving high-intake retinol palmitate, skin dryness and desquamation were the most frequently reported adverse symptoms, occurring in 60% of all treated participants.

  • ModerateCystic fibrosisGrade C

    In nine adult cystic fibrosis patients, one had a raised fasting plasma retinyl ester concentration suggestive of chronic hypervitaminosis A, though no symptoms of toxicity were observed.

  • ModerateHead and neck cancer patients receiving TAR therapy (TS-1, Vitamin A, and radiation)Grade C

    In one patient at level 3 of the TAR therapy regimen (TS-1 combined with Vitamin A intramuscularly and radiation), Grade 4 toxicity of anorexia was observed.

  • ModerateAcne patientsGrade D

    In the studies reviewed, side effects associated with oral vitamin A intake were mainly mucocutaneous in nature.

  • ModerateChildren (large vitamin A intake from candy-like chewable supplements)Grade D

    Serum retinol concentrations took 1 to 3 weeks to peak and many months to normalize following large vitamin A intake in 3 children, indicating a prolonged elevation of circulating retinol.

  • ModerateChildren with high serum vitamin A levelsGrade D

    In healthy Swedish children, the observed pattern of RBP levels relative to vitamin A levels suggested the existence of a toxicity threshold in the interaction between vitamins A and E and RBP.

  • ModerateElderly people / excess intakeGrade D

    Retinol can be toxic when taken in excess, and elderly people may be at particular risk for hypervitaminosis A.

  • ModerateEnd-stage renal failure patients on regular dialysisGrade D

    Patients with end-stage renal failure on regular dialysis had significantly raised plasma vitamin A concentrations compared to normal controls, and these raised levels were reported to contribute to hypervitaminosis A toxicity.

  • ModerateOral Vitamin A use for acneGrade D

    In clinical studies of oral Vitamin A for acne, mucocutaneous side effects and headaches were the most commonly reported adverse effects; both resolved with continued treatment or cessation.

  • MinorPostmenopausal patients with advanced breast cancerGrade C

    In postmenopausal patients receiving retinyl acetate combined with tamoxifen, the most frequent side effects were hot flushes, nausea (and/or vomiting), headache, and cutaneous itching; overall toxicity was generally mild.

Interactions3

  • SeriousTetracyclineGrade D

    In a case of benign intracranial hypertension associated with chronic vitamin A intake, concurrent tetracycline therapy could not be completely excluded as a possible causative factor contributing to the intracranial hypertension.

  • Moderatefat-soluble vitaminsGrade A

    Excessive levels of vitamin A reported to interfere with the metabolism of other fat-soluble vitamins.

  • ModerateOral contraceptivesGrade D

    Plasma retinol homeostasis is tightly controlled by RBP regulation in the liver, and oral contraceptives, as a hormonal factor, are reported to alter this homeostasis.

02What it moves

23 markers studied

One row per marker on the panel that human studies measured. Open a row for the direction, who was studied, and the papers.

Lipids4 of 6 studied

LDL-CMixed resultsGrade C
HDL-CMixed resultsGrade C
TriglyceridesMixed resultsGrade C
Total cholesterolNo changeGrade A

Inflammation3 of 5 studied

hs-CRPRaisesGrade C
IL-6LowersGrade A
TNF-αNo changeGrade C

Blood and iron6 of 7 studied

HemoglobinMixed resultsGrade C
HematocritRaisesGrade C
Red cellsNo changeGrade D
MCVMixed resultsGrade D
White cellsMixed resultsGrade C
FerritinMixed resultsGrade C

Hormones1 of 5 studied

Minerals1 of 5 studied

Also measured358 outcomes

Outcomes these studies measured that are not on the shared panel, so they are not on the map.

Hospitalization timeLowersGrade A
cough durationLowersGrade A
fever durationLowersGrade A
lung rale disappearance timeLowersGrade A
maternal clinical infectionLowersGrade A

Vitamin A lowers maternal clinical infection.

total clinical efficacyRaisesGrade A
breast milk retinol concentrationsRaisesGrade B
modified relative dose response (MRDR)LowersGrade B
Show 32 more
plasma concentrations of vitamin ARaisesGrade B
prevalence of anemia (Hb < 110 g/L)LowersGrade B
%TSRaisesGrade B
Bitot's spotsLowersGrade B
IL-8LowersGrade B
milk retinolRaisesGrade B
retinyl palmitateRaisesGrade B
total-body vitamin A storesRaisesGrade B
β-caroteneRaisesGrade B
maternal night blindnessLowersGrade B

Vitamin A lowers maternal night blindness.

deficient breastmilk and serum retinolLowersGrade C
Response rate in placebo nonresponders crossed over to retinol palmitateRaisesGrade C
24-h lactate clearance rateRaisesGrade C
Actinobacteria abundanceRaisesGrade C
Airway infectionLowersGrade C
Akkermansia abundanceRaisesGrade C
AnaemiaLowersGrade C
anaemia risk (<11.0 g/dL)LowersGrade C
anti-VSACSA IgG to a placental, CSA-adherent isolate (EJ-24)LowersGrade C

Vitamin A lowers anti-VSACSA IgG to a placental, CSA-adherent isolate (EJ-24).

arm circumferenceRaisesGrade C
blurred visionLowersGrade C
body total Fe contentRaisesGrade C
Bronchopulmonary dysplasiaLowersGrade C
bulging fontanelleRaisesGrade C
CCR9+ CD8+ effector memory T cellsLowersGrade C
CD3 + T-cellsLowersGrade C
cellular retinoic-acid-binding protein II (CRABP2)RaisesGrade C

Vitamin A raises cellular retinoic-acid-binding protein II (CRABP2).

chronic graft-versus-host diseaseLowersGrade C
chylomicron free retinolRaisesGrade C
chylomicron retinyl linoleateRaisesGrade C
chylomicron retinyl palmitate/oleateRaisesGrade C
chylomicron retinyl stearateRaisesGrade C

03No result yet

35 markers

35 markers on the panel have no result for Vitamin A yet. A gap is not a negative result.

No trial found18

PubMed searches for human trials of Vitamin A that mention these markers found none we could use (Oct 7, 2026).

Lipids
Lp(a)
Inflammation
ESRFibrinogen
Thyroid
Reverse T3
Oxidative stress
F2-isoprostanes8-OHdG

Only in combination13

Trials measured these, but gave Vitamin A only together with other ingredients, so they can't show its effect alone.

Lipids
ApoB
Liver
Albumin
Hormones
Testosterone
Oxidative stress
MDAGlutathione

Not yet reviewed4

Papers that may report these turned up in the search (Oct 7, 2026) but haven't been fully read yet.

Liver
ALP
Blood and iron
Platelets

04The studies and genetics

Go deeper

The three acts above are free. The paper-by-paper list and the genetics findings are part of the Research plan.
Research planResearch access

Every study and gene finding

Open the strongest papers with their populations and findings, and the gene differences human studies measured.

Compare with

On the evidence map →

Each marker shows the strongest record in the dossier. Records are extracted from published studies by a model pipeline and graded A to D; records whose own notes say no usable human data exists count as no result yet. Research summaries for education, not medical advice. How this page is sourced